Interleukin (IL)-27 is an anti-inflammatory cytokine that stimulates development of IL-10-producing type 1 regulatory T (Tr1) cells in a STAT-1-dependent pathway (12, 13) . Exposure to IL-27 also suppresses Th17 differentiation while stimulating expression of the coinhibitory molecule Tim-3 by T cells (14) (15) (16) . IFN-γ-primed DCs secrete IL-27 and induce IL-10 production by T cells to reduce EAE (17) . WSX-1 (IL-27Rα) and gp130 are subunits of the heterodimeric receptor for IL-27. WSX-1 is expressed in T cells, macrophages, B cells, and DCs (13, (18) (19) (20) . In DCs, IL-27 signaling induces expression of CD39 and B7-H1, which play a suppressive role in EAE development (21, 22) . These observations place IL-27 among key immunomodulatory cytokines; however, the role of IL-27 in peripheral tolerance is not known.
In this study, we investigated the role of IL-27 in peripheral tolerance. Wsx −/− mice with EAE were resistant to tolerance induction by i.v. or oral delivery of Ag, and lack of WSX-1 only in T cells did not abrogate tolerance induction. Conversely, transfer of wild-type (WT) DCs to Wsx −/− mice rendered them susceptible to i.v. tolerance induction. Transfer of IL-10 −/− DCs to Wsx −/− mice abrogated i.v. tolerance induction, showing that peripheral tolerance is dependent, at least in part, on IL-27-induced IL-10 production by DCs. Furthermore, by using isolated specific subsets of splenic DCs, our data suggest the existence of a cooperation among spleen DC subpopulations that leads to increased IFN-γ, IL-10, and L-27 production and suppression of IL-17. Altogether, these observations highlight the pivotal role of IL-27 in induction of peripheral tolerance in autoimmune inflammation and provide a basis for future therapeutic approaches aiming to induce tolerance in patients with MS and other autoimmune diseases. , and STAT1 −/− female mice on the C57BL/6 background were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). Mice were kept in clean cages with a maximum of 5 mice per cage, in a controlled environment with 12/12 h of light/dark cycles and food ad libitum throughout the experimental procedures. Every effort was made to minimize suffering of mice. Experimental protocols were approved by the Institutional Animal Care and Use Committee of Thomas Jefferson University.
MaTerials anD MeThODs

Mice
eae induction and evaluation
Experimental autoimmune encephalomyelitis was induced as previously described (23) . Anesthetized mice were subcutaneously injected with 200 µL of an emulsion containing 200 µg of MOG35-55 peptide (MEVGWYRSPFSRVVHLYRNGK, Genscript, NJ, USA) and equal volume of Complete Freund's adjuvant supplemented with 10 mg/mL of heat-killed Mycobacterium tuberculosis H37Ra. Additionally, mice were intraperitoneally injected with 240 ng of pertussis toxin at immunization time and 48 h later. Disease development was analyzed daily and scored on a 0-5 scale: 0-no clinical signs, 1-limp tail, 2-hind limb weakness, 3-hind limb paralysis, 4-hind limb paralysis and front limb weakness, and 5-full paralysis/death. Cumulative scores were calculated as the sum of all daily scores of each individual mouse divided by the number of mice in each group.
i.v. and Oral administration of auto-ag
Intravenously tolerance was induced as previously described (6) . Briefly, each mouse received 200 µg of MOG35-55 peptide in 100 µL of PBS at days 14, 17, and 21 postimmunization (p.i.). Control mice received PBS only. Induction of oral tolerance followed a previously described protocol (2), where each mouse was given 200 µg of MOG35-55 peptide by oral gavage at days 14, 16, and 18 p.i. and control mice received PBS.
ag-specific recall response
Experimental autoimmune encephalomyelitis mice were dissected at day 21 p.i. and draining lymph nodes and spleens were collected in Iscove's modified Dulbecco's medium (IMDM), supplemented with 10% heat-inactivated fetal bovine serum, penicillin (100 U), streptomycin (10 µg/mL), l-glutamine (0.3 mg/mL), and 2-mercaptoethanol (55 µM) (referred to as complete IMDM) and disrupted through a 70 µm cell strainer to prepare single cell suspensions. After treatment with RBC lysis buffer (Biolegend, CA, USA) cells were extensively washed with complete IMDM by centrifugation at 1,300 rpm for 5 min at 4°C and the cell density was adjusted to 2 million cells/mL. 100 µL of adjusted cell suspension was added to each well of a 96 well plate. The same volume of MOG35-55 (100 µg/mL) was added to wells to a final concentration of 50 µg/mL of antigen. Cells were incubated at 37°C for 72 h. For negative control, cells were cultured without Ag, while cells treated with anti-CD3 and anti-CD28 (1 µg/mL each) served as a positive control. After the incubation period, supernatants were collected and stored at −20°C until use and cells were analyzed for proliferation by flow cytometry.
cytokine Detection in culture supernatants
Supernatants from cell cultures were kept at −20°C until use. Cytokine concentrations in culture supernatants were measured with sandwich enzyme-linked immunosorbent assay (ELISA) using commercial kits, following the manufacturer's recommendation (R&D Systems, Minneapolis, MN, USA). The following cytokines were measured: IFN-γ, IL-17, IL-10, IL-27, and GM-CSF.
isolation of cns cells and Flow cytometry
Mononuclear cells from the CNS of EAE mice were isolated by Percoll gradient centrifugation. In brief, mice were euthanized and perfused with ice-cold PBS. Brains and spinal cords were removed and placed in IMDM, mechanically dissociated with scissors and enzymatically digested by incubation with 700 µg/mL Liberase TL (Sigma-Aldrich, USA) at 37°C for 30 min. The preparation was then washed in IMDM, and the pellet was fractionated on a 70/30% Percoll gradient. MNCs were recovered from the interface, washed, and resuspended in IMDM/10% FBS. One million cells were transferred to FACS tubes. CNS cells were stimulated with PMA (50 ng/mL) and ionomycin (500 ng/mL) 
OVa immunization and Treatment
Anesthetized female WT C57BL/6 mice were subcutaneously injected with 100 µL of an emulsion containing 100 µg of OVA (grade V, Sigma-Aldrich, St. Louis, MO, USA) and an equal volume of CFA supplemented with 4 mg/mL of Heat-Killed Mycobacterium tuberculosis H37Ra. Seven days later, mice were i.v. given 100 µL of OVA-Alexa Fluor 647 (Thermo Fisher Scientific, MA, USA). Mice were dissected after 2 h of OVA injection, and spleens, draining, and mesenteric lymph nodes were collected, stained, and analyzed by flow cytometry.
Dc sorting and culture
Splenic CD11c
+ DCs were isolated from spleens from MOG35-55-tolerized and non-tolerized EAE mice using magnetic beads (CD11c + cell isolation kit, Miltenyi Biotec, CA, USA). Isolated DCs were surface stained with antibodies against CD11c, CD11b, and CD103 for 20 min at 4°C and then sorted into four CD11c + T cells were added to each well of the cell culture plate containing DCs (ratio of 1 DC: 10 T cells) and plates were incubated at 37°C in the presence of anti-CD3 (0.5 µg/mL). Cells were collected after 72 h and analyzed by flow cytometry, while cytokine concentrations in culture supernatants were measured by ELISA.
generation of Bone Marrow-Derived Dcs
Dendritic cells were generated from bone marrow precursors, according to a previously described protocol (24, 25) . Briefly, precursors from WT mice were seeded at 1 million cells/mL in Petri dish in complete IMDM supplemented with 10 ng/mL of GM-CSF. Culture medium was changed on days 3 and 6. At day 7, cells were collected, washed in fresh complete media and transferred to appropriate culture plates for specific treatments. Maturation of the DCs was induced with lipopolysaccharide (100 ng/mL) and cells were cultured in the presence/absence of IL-27 (20 ng/mL) for 18 h and used in Ag-presentation assays or adoptive transfer experiments.
statistical analysis
Daily clinical scores among experimental groups in EAE were compared by two-way ANOVA and posttested with Sidak. Analyses between three or more groups were performed with one-way ANOVA and posttested with Bonferroni. Comparisons between two groups were carried out with Student's t-test. Values of p < 0.05 were considered significant. 
CD4
+ T cells ( Figure 1D ). However, due to lower numbers of infiltrating cells in the CNS of WT mice treated with MOG35-55, absolute numbers of IL-10
, and GM-CSF + CD4 + T cells were reduced in these mice compared to other groups ( Figure 1D ). In addition, cytokine production from Ag-specific ex vivo re-stimulated spleen cells from WT MOG-treated mice revealed a shift toward IL-10 and IL-27 production and suppression of IL-17, GM-CSF and IFN-γ production compared to cells from PBS-treated mice, whereas The Role of IL-27 in Peripheral Tolerance such a pattern was not observed in cultures from Wsx −/− mice ( Figure 1E) . In summary, i.v. tolerance in EAE is followed by a modulation of the immune response in the CNS and secondary lymphoid organs in an IL-27-dependent manner.
In order to investigate whether IL-27 is also necessary for oral tolerance induction, WT and Wsx −/− EAE mice were fed with three 200 µg doses of MOG35-55 every other day starting at disease onset. Similar to the i.v. tolerance model, WT mice fed with MOG35-55 developed significantly less severe EAE compared to PBS-fed mice, but this effect was not observed in Wsx DC maturation was suppressed in MOG-fed WT mice, but not in other groups (Figure S1C in Supplementary Material). As previously described by our group (6), DCs from i.v. tolerized mice also show reduced expression of Ag-presenting molecules (data not shown). Interestingly, oral tolerance seems less effective than i.v. tolerance in suppressing EAE. We speculate that MOG peptide is readily available to APCs and T cells following i.v. administration, whereas gastric acid and oral mucosa barrier may interfere with the bioavailability of orally delivered peptides. We believe that oral and i.v. administration of peptides leads to tolerance through different pathways that converge in IL-27R signaling as both approaches (i.v. and oral tolerance) failed to suppress disease in Wsx −/− mice. Taken together, these observations indicate that IL-27 is a key cytokine for inducing peripheral tolerance via i.v. and oral route.
il-27 signaling in T cells is Dispensable for induction of Peripheral Tolerance
To determine whether IL-27 signaling in T cells plays a role in tolerance induction, we reconstituted RAG1 + , and GM-CSF + CD4 + T cells were reduced in these mice compared to PBS-treated groups ( Figure 1D) . Interestingly, IL-10 + and Foxp3 + CD4 + T cell numbers were comparable between PBS and MOG-treated groups ( Figure 2D ). Tolerized mice also had a higher frequency of spleen Foxp3
+ Treg cells compared to PBS-treated mice, irrespective of WSX expression (data not shown). These results suggest that IL-27 signaling in T cells is not necessary for immune modulation after i.v. delivery of auto-Ag.
il-27rα expression by Dcs is required for Peripheral Tolerance induction via a Mechanism That is Dependent on il-10 Production by Dcs
Given that DCs also express WSX, we then analyzed the frequency and phenotype of DCs in the CNS of RAG-1 −/− mice reconstituted with WT and Wsx −/− CD4 + T cells. i.v. tolerized mice had a higher frequency of DCs in the CNS and these cells expressed less MHC class II and CD80 ( Figure 3A) . DCs from i.v. tolerized mice also produced higher levels of IL-10 compared to PBS-treated mice ( Figure 3B ). Of note, DCs from i.v. tolerized mice that received Wsx −/− T cells had fewer IL-10 + DCs compared to i.v. tolerized mice that were reconstituted with WT T cells ( Figure 3B ). These observations indicate that IL-27 signaling in non-CD4 + T cells, such as DCs, is required for induction of Ag-specific tolerance in ongoing inflammation.
We then investigated the role of IL-27 signaling in DCs in i.v. tolerance induction. CNS-infiltrating DCs obtained from i.v. MOG35-55-treated WT mice with EAE had higher IL-10 production compared to PBS-treated controls ( Figure 3C) . No significant change in IL-27 production was observed between DCs from PBS and MOG35-55-treated groups ( Figure 3C ). DCs from CNS of i.v. tolerized mice also showed lower expression levels of MHC-II, CD80, and CD86 molecules compared to PBS-treated counterparts (data not shown). Interestingly, DCs in the CNS expressed significantly higher levels of IL-27Rα compared to T cells, and its expression was increased in i.v. tolerized mice (Figure 3D ). These observations suggested that DCs may be relevant to the role of IL-27 in tolerance induction. Figures 4A,B) . Analysis of CNS-infiltrating T cells from mice that received WT DCs showed that disease amelioration correlated with a reduced infiltration of cells in the CNS (Figure 4C ). Mice recipient of WT DCs showed an increase in the frequencies of IFN-γ-and IL-10-producing T cells and a reduction in frequency of IL-17-and GM-CSF-producing T cells (Figure 4D) . On the other hand, mice that had received Wsx −/− DCs had only minor changes in the frequencies of cytokine-producing T cells in the CNS, although a significant reduction of IL-17 + T cells was observed ( Figure 4D ). Due to a lower infiltration of cells in the CNS of i.v. tolerized mice recipient of WT DCs, absolute numbers of IL-10 + and IFN-γ + CD4 + T cells did not show significant differences compared to their PBS-treated counterparts ( Figure 4D) .
Still, absolute numbers of IL-17
+ and GM-CSF + CD4 + T cells were reduced in i.v. tolerized mice recipient of WT DCs compared to PBS-treated counterparts ( Figure 4D) . In summary, these data show that tolerance induction in ongoing inflammation requires IL-27 signaling in DCs, leading to disease suppression by augmenting IFN-γ and IL-10 production and dampening Th17 and GM-CSF + CD4 + T cells.
Given that STAT1 is the principal signaling molecule downstream of IL-27R in T cells, we tested whether STAT1 is also involved in IL-27-mediated DC modulation. Immature and mature bone marrow-derived DCs were treated with IL-27 for 18 h and their expression of surface markers involved with Ag-presentation was evaluated. Consistent with data from the literature (21), IL-27-treated mature WT DCs had reduced expression of MHC class II, CD80, and CD86 ( Figure S2A Figure 4D) . We did not detect IL-17 in this culture system (data not shown). Upon adoptive transfer into EAE mice, IL-27-treated WT and S1
− DCs ameliorated clinical disease and reduced cellular infiltration in the CNS ( Figure S2D , and GM-CSF + CD4 + T cells were reduced in mice recipient of IL-27-treated WT and S1
− DCs ( Figure S2E in Supplementary Material). These data show that STAT1 signaling is not necessary for IL-27-induced DC modulation.
Next, we tested whether IL-10 production by DCs plays a role in induction of peripheral tolerance. To that end, we reconstituted Wsx −/− mice with WT, Wsx
, or IL-10 −/− CD11c + DCs and subjected EAE mice to i.v. tolerance induction. Lack of IL-10 production by DCs reduced the protective effect of i.v. MOG35-55 administration (Figures 5A,B) . Analysis of CNS-infiltrating cells showed that only mice recipient of WT DCs had a reduction in total cell numbers ( Figure 5C Figure 5D ). Taken together, these observations show that induction of peripheral tolerance in ongoing inflammation relies on IL-27 signaling, which through IL-10-dependent and STAT1-independent mechanisms, modifies DCs to promote IFN-γ and IL-10 production by T cells in the CNS of EAE mice.
specific subsets of splenic Dcs from i.v. Tolerized Mice stimulate iFn-γ, il-10, and il-27 Production in an il-27-Dependent Manner
Given that DCs comprise multiple cell types with distinct functions in immunity, infection and tolerance (26-31), we tested whether a particular DC type has a prominent role in capturing auto-Ag and stimulating T cell response. Based on CD11b and CD103 expression in isolated CD11c + DCs, we distinguished four DC populations (CD11b
+ CD103 + , and CD11b hi CD103 + ) from the spleen of WT mice (Figure 6A) . To determine whether a particular DC subpopulation captures Ag in the course of inflammation, we subcutaneously immunized WT mice with OVA/CFA and i.v. injected Alexa Fluor 647-conjugated OVA (OVA-AF647) 7 days later. Two hours after OVA-AF647 injection, spleens, draining, and mesenteric lymph nodes were collected and assessed for AF647 fluorescence in each DC subset by flow cytometry. OVA-AF647 was primarily captured by CD11b hi CD103 + and CD11b + CD103 + DCs in spleens and, to a lesser extent, in dLN and mLN (Figure 6B) , suggesting that splenic CD103 + DCs predominantly capture i.v. delivered Ags.
We then investigated whether CD103 + DCs from tolerized EAE mice are responsible for T cell modulation. WT Wsx −/− EAE mice were i.v. tolerized and DC subsets from spleens sorted and cultured with naive CD4 + T cells (1 DC: 10 T ratio) for 72 h. CD11b − CD103 − cells did not express CD80, CD86 and MHC-II and were unable to stimulate T cells in vitro (data not shown); therefore, this subpopulation was excluded from further analysis. CD11b + CD103 + DCs from i.v. tolerized WT mice were potent inducers of IFN-γ and IL-10 production compared to other DC subpopulations (Figures 6C,D) . CD11b + CD103 − and CD11b hi CD103 + DCs from WT i.v. tolerized mice suppressed IL-17 production by T cells completely measured by ELISA, even though flow cytometry analysis did not show such suppression pattern (Figures 6C,D) . Corresponding Wsx −/− DCs increased IL-17 production (Figures 6C,D) . Expression of the activation marker CD69 in cultured T cells was significantly lower when cells were cultured with CD11b + CD103 − and CD11b + CD103 + DCs from i.v. tolerized WT mice compared to their PBS-treated counterparts and Wsx −/− DCs ( Figure 6C) . IL-27 production was upregulated in co-cultures with CD11b + CD103 − DCs from MOG-treated WT mice compared to other DC subtypes and DCs from Wsx −/− mice ( Figure 6D) . Interestingly, Wsx −/− DCs failed to stimulate production of IFN-γ and IL-10 but efficiently produced IL-27 ( Figure 6D) . Taken together, our data show that IL-27 induces IL-10 production by DCs to establish peripheral tolerance in ongoing inflammation and that distinct subpopulations of splenic DCs cooperate in this phenomenon.
DiscUssiOn
Ag-specific tolerance is a common goal in transplantation and autoimmune therapies. Peripheral tolerance induced against self and foreign Ags may be achieved by delivering them through "tolerogenic routes" such as nasal, oral, and i.v. (1, 6). Peripheral tolerance is associated with a reduced inflammatory profile of Th cells and a high activity of Tregs and tolerogenic DCs (2, 3, 6, 9). Cytokines, growth factors and glycoproteins are also involved in peripheral tolerance (32, 33) . It has been shown that IL-27 subunits and its receptor are upregulated in EAE (34) . Given that IL-27 is an anti-inflammatory cytokine that induces IL-10 production by T cells and suppresses EAE (12, 35, 36) , we hypothesized that IL-27 plays a role in induction of peripheral tolerance. In this study we show that IL-27 is necessary to establish peripheral tolerance in ongoing autoimmune inflammation. Our data also show that tolerance induction is characterized by reduced infiltration of cells in the CNS, with greater proportions of IL-10 + T cells among infiltrating T cells. Meanwhile, IL-17 and GM-CSF, which promote neuroinflammation (23, (37) (38) (39) , were suppressed.
Given that IL-27 signaling in T cell leads to development of Tr1 cells through STAT1, AhR, and c-MAF transcription factors (13, 14, 16, 40) , and that Tr1 cells secrete IL-10 to suppress autoimmune responses (40, 41) , one would expect that peripheral tolerance requires IL-27 signaling in T cells. However, unexpectedly, we found that lack of IL-27 signaling in T cells did not affect induction of peripheral tolerance, as RAG1 −/− mice reconstituted either with WT or Wsx −/− T cells were similarly susceptible to i.v. tolerance induction. Analysis of the T cells showed comparable frequencies of Tregs and similar production of inflammatory cytokines. This led us to conclude that IL-27 signaling in T cells is disposable for tolerance induction during ongoing inflammation. We speculate that IL-27 signaling in T is irrelevant for i.v. tolerance induction because effector T cells are resistant to the effects of IL-27 (42, 43) . In our system, at the time when i.v. tolerance is induced, which is after EAE onset, encephalitogenic T cell responses have already developed and IL-27 would have no effect over these cells. The encephalitogenicity of Wsx −/− CD4 + T cells has been previously addressed by our group and others (21, 44) . It is known that these cells are more pathogenic than WT T cells. However, in this study we found that WT and Wsx −/− mice developed a similar EAE course. This discrepancy may be due to differences in immunization protocols as in this study we used 200 µg of MOG35-55 and 240 ng of Pertussis toxin while others used 100 µg of peptide and 200 ng of toxin. We speculate that higher doses of MOG35-55 peptide in immunization inoculum could promote cell activation-induced death of Wsx −/− CD4 + T cells or higher stimulation of Treg cells. Given that IL-27 induces tolerogenic DCs that suppress EAE (21), we next tested whether IL-27 signaling in DCs plays a role in i.v. tolerance induction.
It has been shown that DCs are pivotal for tolerance induction via i.v. and mucosal routes (3, 6, 31, 45) . We found that in the CNS of EAE mice DCs express high levels of IL-27Rα, and that its expression is increased in mice subjected to tolerance induction. This observation suggests that DCs may be highly susceptible to IL-27 signaling or that they can respond to low concentrations of IL-27. The presence of DCs that express IL-27Rα rendered Wsx −/− mice susceptible to tolerance induction, showing that IL-27 signaling in DCs, is necessary for establishment of peripheral tolerance to self-Ags during an autoimmune response. Further mechanistic analysis showed that disease amelioration correlated with a decreased frequency of IL-17-and GM-CSFproducing cells and a small increase in IL-10-producing T cells in the CNS. However, T cells were clearly skewed toward a Th1 lineage, as their IFN-γ production increased approximately threefold compared to PBS-treated mice. It has been shown that IFN-γ inhibits IL-17 production and exerts a protective role in EAE, and initial reports characterized IL-27 as a Th1-inducing cytokine (46, 47) . These observations suggest that DC-induced T cell-derived IFN-γ may play a role in IL-27-dependent peripheral tolerance.
Our results show that IL-27 signaling in DCs contributes to peripheral tolerance induction in ongoing EAE and that the mechanisms of DC-mediated control of EAE include (i) suppression of IL-17 and GM-CSF and (ii) stimulation of Treg cells and IFN-γ/IL-10 production by T cells. STATs are a major family of kinases that translate cytokine signals to the nucleus of the cell and promote transcription of specific genes. STAT1 and -3 mediate IL-27 signal in T cells, leading to T-bet, c-MAF, and AhR expression and IL-10 production (13, 20, 40, 46) . In the absence of STAT1, IL-27 has an inflammatory effect and supports differentiation of naive T cells into Th17 lineage (13 as STAT3 is necessary for IL-27-induced expression of CD39, an ectonucleotidase (21) . Apart from CD39, it has been shown that STAT3 also promotes IL-10 production in macrophages and Th17 cells (48, 49) and we observed that DCs from i.v. tolerized mice were proficient producers of IL-10, not IL-27, in the CNS. This led us to hypothesize that IL-27-induced DC-derived IL-10 plays a role in tolerance induction. In agreement with our hypothesis, lack of IL-10 production by DCs precluded the tolerogenic effect of IL-27, even though IL-17 production was suppressed. In this system, lack of disease amelioration correlated with reduced numbers of Tregs in i.v. tolerized mice, which shows that the mechanism of Treg cell expansion is dependent on IL-27-induced DC-derived IL-10. Distinct subsets of DCs have been identified in mouse and human organs, and it is believed that each subset plays a specific role in inflammation and tolerance (26, 28, 30, 31, 50) . In this context, it has been shown that mesenteric lymph node resident classical DCs (Lin − CD11c + CD64 − MHC-II + , cDCs) are important for oral tolerance induction and that absence of MHC class II expression in mLN cDCs leads to colitis (51, 52) . Using CD11b and CD103, we identified three distinct populations of classical DCs in the spleen of mice. Previous reports showed that CD103 + DCs in the gut are potent inducers of oral tolerance and stimulate Treg differentiation through TGF-β and retinoic acid (45, 53) . Our data show that, on the one hand, CD103
+ DCs readily uptake i.v. delivered Ag and that CD11b + CD103 + DCs from i.v. tolerized EAE mice were more efficient in inducing IFN-γ and IL-10. On the other hand, CD103
− and CD11b hi CD103
+ DCs were more efficient in suppressing IL-17 production by naive T cells. Lack of IL-27R in DCs was sufficient to overcome this effect. IL-27 production was greater in cultures with CD103 − DCs from i.v. tolerized mice and this effect was not abrogated in the absence of IL-27Rα in DCs. It has been shown that IL-27 facilitates naive T cell differentiation into Th1 cells even though IL-27 does not induce IFN-γ production directly (19) . Therefore, it would not be surprising if IL-27 acts on both T cells and DCs in the establishment of peripheral tolerance. Our data suggest that IL-27 skews DCs toward a Th1-inducing profile, which leads to suppression of Th17-driven inflammation, such as the case of EAE. Our data indicate that CD103 − DCs may be an initial source of IL-27 following intravenous administration of antigen, although more studies are needed to properly address this possibility.
Overall, our results indicate that an intricate network among DCs subsets results in IL-27-dependent tolerance induction in ongoing inflammation. These findings may indicate the need for research on the use of IL-27 as an adjunct factor for increasing the safety and efficacy of Ag-induced tolerance in harmful immune responses in clinical trials.
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